| |
| | The Cure Our Children Foundation New and Emerging Treatments for Ewing's Sarcoma Weblog ... |
 | | The secondary objectives are to evaluate the safety and tolerability of HGS-ETR1, to determine plasma concentrations of HGS-ETR1 for use in a population pharmacokinetic analysis, and to evaluate other indicators of disease activity, including time to response, duration of response, and progression-free survival. |
 | | Professor Dr. Siegfried Seeber, principal investigator and Director, University Clinic for Internal Medicine and Policlinic (Tumor Research), West German Tumor Center, University of Essen, Germany, said, “Combinations of chemotherapeutic agents and, more recently, monoclonal antibodies, have demonstrated clinical benefit for patients with advanced colorectal cancer, but the prognosis for these patients continues to be poor. |
 | | University of York NHS Centre for Reviews and Dissemination. |
| cureourchildren.blogharbor.com (12858 words) |
|